This study evaluated the performance of Nobori biolimus bio-absorbable polymer stent in real-world patients. A total of 3067 consecutive patients followed up to 5 years were included.
The rate of target lesion (composite of cardiac death, myocardial infarction and target lesion revascularization) was 3.9% at one year and 5.1% at 2 years. Long-term clinical performance was favorable with very low stent related events and no thrombosis between 3 and 5 years.
G. B. Danzi
2014-05-23
Title: Final 5-year clinical outcomes of large multicentre Nobori 2 study
